Terms: = Germ cell tumor AND PTEN, MMAC1, 5728, MGC11227, PTEN1, MHAM, P60484, BZS, ENSG00000171862 AND Prognosis
287 results:
1. Role of Surgery in Metastatic Melanoma and Review of Melanoma Molecular Characteristics.
Sukniam K; Manaise HK; Popp K; Popp R; Gabriel E
Cells; 2024 Mar; 13(6):. PubMed ID: 38534309
[TBL] [Abstract] [Full Text] [Related]
2. Molecular signature of stem-like glioma cells (SLGCs) from human glioblastoma and gliosarcoma.
Zechel C; Loy M; Wegner C; Dahlke E; Soetje B; Baehr L; Leppert J; Ostermaier JJ; Lueg T; Nielsen J; Elßner J; Willeke V; Marzahl S; Tronnier V; Madany Mamlouk A
PLoS One; 2024; 19(2):e0291368. PubMed ID: 38306361
[TBL] [Abstract] [Full Text] [Related]
3. nSEA: n-Node Subnetwork Enumeration Algorithm Identifies Lower Grade Glioma Subtypes with Altered Subnetworks and Distinct Prognostics.
Zhang Z; Wang C; Zhao Z; Yi Z; Durmaz A; Yu JS; Bebek G
Pac Symp Biocomput; 2024; 29():521-533. PubMed ID: 38160304
[TBL] [Abstract] [Full Text] [Related]
4. [Interaction of SENP6 with PINK1 Promotes Temozolomide Resistance in Neuroglioma cells via Inducing the Mitophagy].
Wang YW; Jia KG; Xing HJ; Pan Y; Zeng CS; Chen L; Su QJ; Shen WT; Chen J; Chen C; Cao Q; Wang YY
Mol Biol (Mosk); 2023; 57(6):31-40. PubMed ID: 38062972
[TBL] [Abstract] [Full Text] [Related]
5. Multiomics blueprint of PANoptosis in deciphering immune characteristics and prognosis stratification of glioma patients.
Chen M; Huang M; Chen X; Lin X; Chen X
J Gene Med; 2024 Jan; 26(1):e3621. PubMed ID: 37997255
[TBL] [Abstract] [Full Text] [Related]
6. Genetic Aspects of Conjunctival Melanoma: A Review.
Chang E; Demirci H; Demirci FY
Genes (Basel); 2023 Aug; 14(9):. PubMed ID: 37761808
[TBL] [Abstract] [Full Text] [Related]
7. Spinster homolog 2 reduces malignancies of glioblastoma via pten/PI3K/AKT pathway.
Liang W; Liu M; Su Y; Wen Y; Wang L; Shan J; Zhao J; Xie K; Wang J
IUBMB Life; 2024 Mar; 76(3):140-160. PubMed ID: 37728571
[TBL] [Abstract] [Full Text] [Related]
8. CD39 and LDHA affects the prognostic role of NLR in metastatic melanoma patients treated with immunotherapy.
Mallardo D; Fordellone M; White A; Ottaviano M; Sparano F; Bailey M; Facchini AB; Ong S; Maiolino P; Caracò C; Church S; Cavalcanti E; Warren S; Budillon A; Cesano A; Simeone E; Chiodini P; Ascierto PA
J Transl Med; 2023 Sep; 21(1):610. PubMed ID: 37684649
[TBL] [Abstract] [Full Text] [Related]
9. The Genomic and Epigenomic Landscape of Double-Negative Metastatic Prostate Cancer.
Lundberg A; Zhang M; Aggarwal R; Li H; Zhang L; Foye A; Sjöström M; Chou J; Chang K; Moreno-Rodriguez T; Shrestha R; Baskin A; Zhu X; Weinstein AS; Younger N; Alumkal JJ; Beer TM; Chi KN; Evans CP; Gleave M; Lara PN; Reiter RE; Rettig MB; Witte ON; Wyatt AW; Feng FY; Small EJ; Quigley DA
Cancer Res; 2023 Aug; 83(16):2763-2774. PubMed ID: 37289025
[TBL] [Abstract] [Full Text] [Related]
10. Clinical and Proteomic-Based Molecular Characterizations of Invasive and Noninvasive Somatotroph PitNETs.
Chen M; Duan L; Sun W; Guo Z; Miao H; Yu N; Yang S; Wang L; Gong F; Yao Y; Zhu H
Neuroendocrinology; 2023; 113(9):971-986. PubMed ID: 37253344
[TBL] [Abstract] [Full Text] [Related]
11. Spatial Gene Expression Analysis Reveals Characteristic Gene Expression Patterns of De Novo Neuroendocrine Prostate Cancer Coexisting with Androgen Receptor Pathway Prostate Cancer.
Watanabe R; Miura N; Kurata M; Kitazawa R; Kikugawa T; Saika T
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240308
[TBL] [Abstract] [Full Text] [Related]
12. Molecular and Functional Heterogeneity of Primary Pancreatic Neuroendocrine tumors and Metastases.
Guo Y; Tian C; Cheng Z; Chen R; Li Y; Su F; Shi Y; Tan H
Neuroendocrinology; 2023; 113(9):943-956. PubMed ID: 37232011
[TBL] [Abstract] [Full Text] [Related]
13. Identification of INSRR as an immune-related gene in the tumor microenvironment of glioblastoma by integrated bioinformatics analysis.
Zhang H; Bao M; Liao D; Zhang Z; Tian Z; Yang E; Luo P; Jiang X
Med Oncol; 2023 Apr; 40(6):161. PubMed ID: 37099121
[TBL] [Abstract] [Full Text] [Related]
14. Hsa_circITGA4/ miR-1468/EGFR/ pten a Master Regulators Axis in Glioblastoma Development and Progression.
Tutunchi S; Bereimipour A; Ghaderian SMH
Mol Biotechnol; 2024 Jan; 66(1):90-101. PubMed ID: 37031335
[TBL] [Abstract] [Full Text] [Related]
15. Progress in targeting pten/PI3K/Akt axis in glioblastoma therapy: Revisiting molecular interactions.
Hashemi M; Etemad S; Rezaei S; Ziaolhagh S; Rajabi R; Rahmanian P; Abdi S; Koohpar ZK; Rafiei R; Raei B; Ahmadi F; Salimimoghadam S; Aref AR; Zandieh MA; Entezari M; Taheriazam A; Hushmandi K
Biomed Pharmacother; 2023 Feb; 158():114204. PubMed ID: 36916430
[TBL] [Abstract] [Full Text] [Related]
16.
Flores Legarreta A; Salvo G; Gonzales NR; Chisholm G; Hillman RT; Frumovitz M
J Gynecol Oncol; 2023 Jul; 34(4):e50. PubMed ID: 36807750
[TBL] [Abstract] [Full Text] [Related]
17. Resveratrol inhibits glioblastoma cells and chemoresistance progression through blockade P-glycoprotein and targeting AKT/pten signaling pathway.
Zhang Y; Zhang Z; Mousavi M; Moliani A; Bahman Y; Bagheri H
Chem Biol Interact; 2023 May; 376():110409. PubMed ID: 36804490
[TBL] [Abstract] [Full Text] [Related]
18. Yes-Associated Protein Nuclear Translocation Is Regulated by Epidermal Growth Factor Receptor Activation Through Phosphatase and Tensin Homolog/AKT Axis in Glioblastomas.
Masliantsev K; Mordrel M; Banor T; Desette A; Godet J; Milin S; Wager M; Karayan-Tapon L; Guichet PO
Lab Invest; 2023 May; 103(5):100053. PubMed ID: 36801645
[TBL] [Abstract] [Full Text] [Related]
19. The pten-associated immune prognostic signature reveals the landscape of the tumor microenvironment in glioblastoma.
Yu J; Lai M; Zhou Z; Zhou J; Hu Q; Li J; Li H; Chen L; Wen L; Zhou M; Cai L
J Neuroimmunol; 2023 Mar; 376():578034. PubMed ID: 36791582
[TBL] [Abstract] [Full Text] [Related]
20. Plasma circulating tumor DNA profiling in patients with chemo-refractory germ cell tumors.
Sakka S; Kandori S; Kawai K; Kojima T; Nitta S; Chihara I; Nagumo Y; Kawahara T; Mathis BJ; Ishihara M; Shinohara N; Kishida T; Ukimura O; Nishimura K; Kobayashi Y; Nishiyama H
Int J Urol; 2023 May; 30(5):456-462. PubMed ID: 36746673
[TBL] [Abstract] [Full Text] [Related]
[Next]
